Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Boris Hadaschik

Showing results (61-70 of 268) with videos related to

Pageof 27
Sort By:
The Journal of Urology|September 29, 2012
Impact of complete bladder neck preservation on urinary continence, quality of life and surgical margins after radical prostatectomy: a randomized, controlled, single blind trialJoanne N Nyarangi-Dix, Jan Philipp Radtke, Boris Hadaschik, et al.
Genes|March 25, 2022
Proteasomal Processing Immune Escape Mechanisms in Platinum-Treated Advanced Bladder CancerMichael Wessolly, Fabian D Mairinger, Thomas Herold, et al.
Urologie (Heidelberg, Germany)|January 22, 2025
[Role of prostate-specific membrane antigen positron emission tomography/computed tomography (PSMA-PET/CT) in staging]Claudia Kesch, Tobias Franiel, Christoph Berliner, et al.
World Journal of Radiology|August 3, 2013
Prostate magnetic resonance imaging at 3 Tesla: Is administration of hyoscine-N-butyl-bromide mandatory?Matthias C Roethke, Timur H Kuru, Alexander Radbruch, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 15, 2022
Is <sup>18</sup>F-FDG PET Needed to Assess <sup>177</sup>Lu-PSMA Therapy Eligibility? A VISION-like, Single-Center AnalysisRobert Seifert, Tugce Telli, Boris Hadaschik, et al.
Cancers|January 21, 2023
Metastatic Prostate Cancer-A Review of Current Treatment Options and Promising New ApproachesPhilip Posdzich, Christopher Darr, Thomas Hilser, et al.
BMC Cancer|March 22, 2012
Characterization of colon cancer cells: a functional approach characterizing CD133 as a potential stem cell markerMeike Schneider, Johannes Huber, Boris Hadaschik, et al.
Frontiers in Oncology|April 19, 2021
The Biomarker Potential of Caveolin-1 in Penile CancerAndrej Panic, Henning Reis, Alina Wittka, et al.
Radiologie (Heidelberg, Germany)|September 16, 2022
[Oncological theranostics in nuclear medicine]Christina Laschinsky, Ken Herrmann, Wolfgang Fendler, et al.
Patient Education and Counseling|September 28, 2011
Multimedia support in preoperative patient education for radical prostatectomy: the physicians' point of viewAndreas Ihrig, Wolfgang Herzog, Christian G Huber, et al.
Pageof 27

Showing results (61-70 of 268) with videos related to

Sort By:
Pageof 27
The Journal of Urology|September 29, 2012
Impact of complete bladder neck preservation on urinary continence, quality of life and surgical margins after radical prostatectomy: a randomized, controlled, single blind trialJoanne N Nyarangi-Dix, Jan Philipp Radtke, Boris Hadaschik, et al.
Genes|March 25, 2022
Proteasomal Processing Immune Escape Mechanisms in Platinum-Treated Advanced Bladder CancerMichael Wessolly, Fabian D Mairinger, Thomas Herold, et al.
Urologie (Heidelberg, Germany)|January 22, 2025
[Role of prostate-specific membrane antigen positron emission tomography/computed tomography (PSMA-PET/CT) in staging]Claudia Kesch, Tobias Franiel, Christoph Berliner, et al.
World Journal of Radiology|August 3, 2013
Prostate magnetic resonance imaging at 3 Tesla: Is administration of hyoscine-N-butyl-bromide mandatory?Matthias C Roethke, Timur H Kuru, Alexander Radbruch, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 15, 2022
Is <sup>18</sup>F-FDG PET Needed to Assess <sup>177</sup>Lu-PSMA Therapy Eligibility? A VISION-like, Single-Center AnalysisRobert Seifert, Tugce Telli, Boris Hadaschik, et al.
Cancers|January 21, 2023
Metastatic Prostate Cancer-A Review of Current Treatment Options and Promising New ApproachesPhilip Posdzich, Christopher Darr, Thomas Hilser, et al.
BMC Cancer|March 22, 2012
Characterization of colon cancer cells: a functional approach characterizing CD133 as a potential stem cell markerMeike Schneider, Johannes Huber, Boris Hadaschik, et al.
Frontiers in Oncology|April 19, 2021
The Biomarker Potential of Caveolin-1 in Penile CancerAndrej Panic, Henning Reis, Alina Wittka, et al.
Radiologie (Heidelberg, Germany)|September 16, 2022
[Oncological theranostics in nuclear medicine]Christina Laschinsky, Ken Herrmann, Wolfgang Fendler, et al.
Patient Education and Counseling|September 28, 2011
Multimedia support in preoperative patient education for radical prostatectomy: the physicians' point of viewAndreas Ihrig, Wolfgang Herzog, Christian G Huber, et al.
Pageof 27